Cargando…

Noninvasive ventilation for acute lung injury: how often should we try, how often should we fail?

The selection of patients with acute lung injury/acute respiratory distress syndrome (ALI/ARDS) to receive noninvasive ventilation (NIV) is challenging, partly because there are few reliable selection criteria. The study by Rana and colleagues in the previous issue of Critical Care identifies metabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Garpestad, Erik, Hill, Nicholas S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750989/
https://www.ncbi.nlm.nih.gov/pubmed/16879722
http://dx.doi.org/10.1186/cc4960
_version_ 1782131400847130624
author Garpestad, Erik
Hill, Nicholas S
author_facet Garpestad, Erik
Hill, Nicholas S
author_sort Garpestad, Erik
collection PubMed
description The selection of patients with acute lung injury/acute respiratory distress syndrome (ALI/ARDS) to receive noninvasive ventilation (NIV) is challenging, partly because there are few reliable selection criteria. The study by Rana and colleagues in the previous issue of Critical Care identifies metabolic acidosis and a lower oxygenation index as predictors of NIV failure, although it is unable to identify threshold values. It also demonstrates that treating patients with NIV for ALI/ARDS and shock is an exercise in futility. Future studies need to focus on criteria that will enable selection of patients for whom NIV will have a high likelihood of success.
format Text
id pubmed-1750989
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-17509892006-12-27 Noninvasive ventilation for acute lung injury: how often should we try, how often should we fail? Garpestad, Erik Hill, Nicholas S Crit Care Commentary The selection of patients with acute lung injury/acute respiratory distress syndrome (ALI/ARDS) to receive noninvasive ventilation (NIV) is challenging, partly because there are few reliable selection criteria. The study by Rana and colleagues in the previous issue of Critical Care identifies metabolic acidosis and a lower oxygenation index as predictors of NIV failure, although it is unable to identify threshold values. It also demonstrates that treating patients with NIV for ALI/ARDS and shock is an exercise in futility. Future studies need to focus on criteria that will enable selection of patients for whom NIV will have a high likelihood of success. BioMed Central 2006 2006-07-12 /pmc/articles/PMC1750989/ /pubmed/16879722 http://dx.doi.org/10.1186/cc4960 Text en Copyright © 2006 BioMed Central Ltd
spellingShingle Commentary
Garpestad, Erik
Hill, Nicholas S
Noninvasive ventilation for acute lung injury: how often should we try, how often should we fail?
title Noninvasive ventilation for acute lung injury: how often should we try, how often should we fail?
title_full Noninvasive ventilation for acute lung injury: how often should we try, how often should we fail?
title_fullStr Noninvasive ventilation for acute lung injury: how often should we try, how often should we fail?
title_full_unstemmed Noninvasive ventilation for acute lung injury: how often should we try, how often should we fail?
title_short Noninvasive ventilation for acute lung injury: how often should we try, how often should we fail?
title_sort noninvasive ventilation for acute lung injury: how often should we try, how often should we fail?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750989/
https://www.ncbi.nlm.nih.gov/pubmed/16879722
http://dx.doi.org/10.1186/cc4960
work_keys_str_mv AT garpestaderik noninvasiveventilationforacutelunginjuryhowoftenshouldwetryhowoftenshouldwefail
AT hillnicholass noninvasiveventilationforacutelunginjuryhowoftenshouldwetryhowoftenshouldwefail